Bernard Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5K Sell
808
-113
-12% -$2.96K 0.01% 192
2026
Q1
$25.9K Buy
921
+2
+0.2% +$53 0.01% 167
2025
Q4
$22.9K Buy
919
+2
+0.2% +$50 0.01% 177
2025
Q3
$23.4K Buy
917
+2
+0.2% +$49 0.01% 177
2025
Q2
$22.2K Sell
915
-184
-17% -$4.29K 0.01% 174
2025
Q1
$27.9K Sell
1,099
-37
-3% -$968 0.01% 158
2024
Q4
$30.1K Buy
+1,136
New +$30.8K 0.01% 156

Other funds holding PFE

Bernard Wealth Management's PFE Position: Q2 2026 in Review

Bernard Wealth Management reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $2.96K and leaving 808 shares worth $19.5K. The position accounts for 0.01% of the portfolio, ranked #192.

Bernard Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.1K in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bernard Wealth Management held 808 shares of Pfizer worth $19.5K as of Q2 2026.
  • Bernard Wealth Management sold 113 Pfizer shares in Q2 2026, an estimated $2.96K.
  • Pfizer made up 0.01% of Bernard Wealth Management's portfolio in Q2 2026, its #192 holding.
  • Bernard Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Bernard Wealth Management's Pfizer position peaked at $30.1K in Q4 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bernard Wealth Management's 13F filing for Q2 2026, filed 21 Aug 2026.